NfL is a well-studied blood biomarker test that is now widely available through Labcorp for assessing neuronal damage from neurodegenerative diseases and sports-related concussion.

Finding a way to diagnose Alzheimer's earlier and easier is a key goal for Labcorp.

Genetics can play a significant role in the development of certain neurodegenerative diseases. In some cases, genetic testing may help confirm a diagnosis.

The increasing prevalence of neurodegenerative diseases has fueled the need for advanced research into therapeutic solutions and related neurodegenerative biomarkers.

While no single test can diagnose multiple sclerosis, lab tests may help doctors rule out other diseases and confirm a diagnosis.

Characterized by progressive muscle loss and weakness, our tests can detect the genetic mutations that cause the most common forms.